Nada Elbuluk, MD, MSc, FAAD

The panel turns to taking a thorough patient history, performing a complete physical exam, and ordering appropriate laboratory workup when evaluating a patient with vitiligo.

The panel reframe vitiligo as a chronic autoimmune disease affecting 1–2% of the global population, emphasizing its clinical presentations, associated comorbidities, and significant psychosocial impact on patients across all skin types.